Dikhyaa Mohanty 
The UK finally approved the Oxford University-AstraZenecas COVID-19 vaccine for use. After the authorization by the country’s medicines regulator, the UK government finally accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorize Oxford University/AstraZeneca’s Covid-19 vaccine for use.
The Medicines and Healthcare products Regulatory Agency (MHRA) concluded that after following rigorous clinical trials and a thorough analysis of the data by experts the vaccine has met its strict standards of safety, quality, and effectiveness. The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the priority groups to receive this vaccine.
Recently the UK has already given the vaccine to many patients with Pfizer/BioNTech vaccine. According to the report, the National Health Service (NHS) in the UK will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine.
The Joint Committee on Vaccination and Immunisation has advised that the priority will be given as many people at risk group by giving their first dose rather than providing the required two doses in as short a time as possible. And everyone will still receive their second dose within 12 weeks of their first. The NHS across the UK will prioritize by giving the first dose of the vaccine to the people who are at the higher risk groups. With the approval of the two vaccines now the government will able to vaccinate a greater number of people.
Image Source : Google
